A Trial of Patients With a Charles Bonnet Syndrome
キーワード
概要
説明
Patients with a visual acuity of 0.5 LogMAR or less in the better eye were screened for CBS. Instruments used were an interview asking for details of the hallucinations, a mental test and a scale concerning quality of life. Patients with CBS were randomized by minimization in two groups: in group 1, a patient-doctor interview by an ophthalmologist was performed and in group 2 an interview and if needed, a therapy by a psychiatrist. At the 3-months follow up, the psychological strain of patients was recorded again.
日付
最終確認済み: | 05/31/2017 |
最初に提出された: | 02/08/2017 |
提出された推定登録数: | 05/07/2017 |
最初の投稿: | 05/09/2017 |
最終更新が送信されました: | 06/25/2017 |
最終更新日: | 06/26/2017 |
実際の研究開始日: | 10/09/2014 |
一次完了予定日: | 02/16/2016 |
研究完了予定日: | 01/31/2017 |
状態または病気
介入/治療
Other: interview
段階
アームグループ
腕 | 介入/治療 |
---|---|
Experimental: interview with an ophthalmologist Patients get an interview with an ophthalmologist | |
Experimental: interview/treatment by a psychiatrist patients get an interview and a possible treatment by a psychiatrist |
適格基準
研究の対象となる年齢 | 55 Years に 55 Years |
研究に適格な性別 | All |
健康なボランティアを受け入れる | はい |
基準 | Inclusion Criteria: - written informed consent - visual acuity of 0.5 LogMAR or less at both eyes - 55 years or older Patients with CBS: - have no mental pathologies such as dementia, psychosis or any other neurological diseases - have a normal cognitive state - are not able to control the VH - know that the VH are not real - are usually older - have significantly reduced visual acuity due to an bilateral eye pathology VH associated with CBS: - disappear when the eyes are closed - are repetitive - are complex (eg. objects, geometrical patterns, faces, shapes, figures, scenes, animals or plants) Exclusion Criteria: - dopamine agonist medication - temporal lobe epilepsy - moderate to severe Alzheimer's dementia - present chronic alcohol-/drug abuse - bad cognitive state There are no: - auditory or olfactory hallucinations - other abnormalities like delusions |
結果
主な結果の測定
1. Quality of life score between the two groups [3 months]